INCYTE CORP (INCY) Fundamental Analysis & Valuation
NASDAQ:INCY • US45337C1027
Current stock price
97.1 USD
-0.59 (-0.6%)
At close:
95.5785 USD
-1.52 (-1.57%)
After Hours:
This INCY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. INCY Profitability Analysis
1.1 Basic Checks
- INCY had positive earnings in the past year.
- In the past year INCY had a positive cash flow from operations.
- INCY had positive earnings in each of the past 5 years.
- INCY had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With an excellent Return On Assets value of 18.49%, INCY belongs to the best of the industry, outperforming 95.93% of the companies in the same industry.
- The Return On Equity of INCY (24.90%) is better than 96.12% of its industry peers.
- INCY's Return On Invested Capital of 19.49% is amongst the best of the industry. INCY outperforms 97.48% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for INCY is significantly below the industry average of 27.73%.
- The last Return On Invested Capital (19.49%) for INCY is above the 3 year average (10.37%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.49% | ||
| ROE | 24.9% | ||
| ROIC | 19.49% |
ROA(3y)9.3%
ROA(5y)10.59%
ROE(3y)12.45%
ROE(5y)14.06%
ROIC(3y)10.37%
ROIC(5y)10.71%
1.3 Margins
- INCY's Profit Margin of 25.03% is amongst the best of the industry. INCY outperforms 93.41% of its industry peers.
- In the last couple of years the Profit Margin of INCY has grown nicely.
- Looking at the Operating Margin, with a value of 26.12%, INCY belongs to the top of the industry, outperforming 94.57% of the companies in the same industry.
- In the last couple of years the Operating Margin of INCY has grown nicely.
- Looking at the Gross Margin, with a value of 93.26%, INCY belongs to the top of the industry, outperforming 93.99% of the companies in the same industry.
- INCY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.12% | ||
| PM (TTM) | 25.03% | ||
| GM | 93.26% |
OM growth 3Y13.93%
OM growth 5YN/A
PM growth 3Y35.6%
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y-0.55%
2. INCY Health Analysis
2.1 Basic Checks
- INCY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- INCY has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for INCY has been reduced compared to 5 years ago.
- The debt/assets ratio for INCY has been reduced compared to a year ago.
2.2 Solvency
- INCY has an Altman-Z score of 8.54. This indicates that INCY is financially healthy and has little risk of bankruptcy at the moment.
- With a decent Altman-Z score value of 8.54, INCY is doing good in the industry, outperforming 79.65% of the companies in the same industry.
- The Debt to FCF ratio of INCY is 0.03, which is an excellent value as it means it would take INCY, only 0.03 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 0.03, INCY belongs to the best of the industry, outperforming 96.32% of the companies in the same industry.
- A Debt/Equity ratio of 0.01 indicates that INCY is not too dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.01, INCY is in line with its industry, outperforming 47.09% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.03 | ||
| Altman-Z | 8.54 |
ROIC/WACC2.14
WACC9.11%
2.3 Liquidity
- INCY has a Current Ratio of 3.32. This indicates that INCY is financially healthy and has no problem in meeting its short term obligations.
- INCY has a Current ratio (3.32) which is in line with its industry peers.
- A Quick Ratio of 3.25 indicates that INCY has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 3.25, INCY is in line with its industry, outperforming 41.28% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.32 | ||
| Quick Ratio | 3.25 |
3. INCY Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 414.39% over the past year.
- INCY shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 34.67% yearly.
- The Revenue has grown by 21.22% in the past year. This is a very strong growth!
- Measured over the past years, INCY shows a quite strong growth in Revenue. The Revenue has been growing by 14.03% on average per year.
EPS 1Y (TTM)414.39%
EPS 3Y34.67%
EPS 5YN/A
EPS Q2Q%25.87%
Revenue 1Y (TTM)21.22%
Revenue growth 3Y14.84%
Revenue growth 5Y14.03%
Sales Q2Q%27.84%
3.2 Future
- INCY is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -8.29% yearly.
- INCY is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.83% yearly.
EPS Next Y13.99%
EPS Next 2Y16%
EPS Next 3Y11.72%
EPS Next 5Y-8.29%
Revenue Next Year11.92%
Revenue Next 2Y11.45%
Revenue Next 3Y8.53%
Revenue Next 5Y-0.83%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. INCY Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 14.30, the valuation of INCY can be described as correct.
- Compared to the rest of the industry, the Price/Earnings ratio of INCY indicates a rather cheap valuation: INCY is cheaper than 96.12% of the companies listed in the same industry.
- INCY is valuated rather cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
- With a Price/Forward Earnings ratio of 12.55, INCY is valued correctly.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of INCY indicates a rather cheap valuation: INCY is cheaper than 97.67% of the companies listed in the same industry.
- When comparing the Price/Forward Earnings ratio of INCY to the average of the S&P500 Index (38.20), we can say INCY is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.3 | ||
| Fwd PE | 12.55 |
4.2 Price Multiples
- INCY's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. INCY is cheaper than 96.12% of the companies in the same industry.
- INCY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. INCY is cheaper than 97.09% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.27 | ||
| EV/EBITDA | 10.73 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- INCY has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.02
PEG (5Y)N/A
EPS Next 2Y16%
EPS Next 3Y11.72%
5. INCY Dividend Analysis
5.1 Amount
- INCY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
INCY Fundamentals: All Metrics, Ratios and Statistics
97.1
-0.59 (-0.6%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-10 2026-02-10/bmo
Earnings (Next)04-28 2026-04-28
Inst Owners104.89%
Inst Owner Change0.05%
Ins Owners0.92%
Ins Owner Change-10.99%
Market Cap19.32B
Revenue(TTM)5.14B
Net Income(TTM)1.29B
Analysts73.94
Price Target109.33 (12.6%)
Short Float %5.87%
Short Ratio6.67
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.64%
Min EPS beat(2)-8.46%
Max EPS beat(2)33.74%
EPS beat(4)3
Avg EPS beat(4)10.48%
Min EPS beat(4)-8.46%
Max EPS beat(4)33.74%
EPS beat(8)3
Avg EPS beat(8)-1.32%
EPS beat(12)5
Avg EPS beat(12)-4.16%
EPS beat(16)7
Avg EPS beat(16)-3.27%
Revenue beat(2)2
Avg Revenue beat(2)7.99%
Min Revenue beat(2)6.72%
Max Revenue beat(2)9.27%
Revenue beat(4)4
Avg Revenue beat(4)5.84%
Min Revenue beat(4)3.45%
Max Revenue beat(4)9.27%
Revenue beat(8)6
Avg Revenue beat(8)2.66%
Revenue beat(12)7
Avg Revenue beat(12)0.75%
Revenue beat(16)9
Avg Revenue beat(16)0.81%
PT rev (1m)0.01%
PT rev (3m)7.5%
EPS NQ rev (1m)1.99%
EPS NQ rev (3m)-14.27%
EPS NY rev (1m)1.06%
EPS NY rev (3m)-3.82%
Revenue NQ rev (1m)-1.56%
Revenue NQ rev (3m)-0.55%
Revenue NY rev (1m)-0.44%
Revenue NY rev (3m)1.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.3 | ||
| Fwd PE | 12.55 | ||
| P/S | 3.76 | ||
| P/FCF | 14.27 | ||
| P/OCF | 13.67 | ||
| P/B | 3.74 | ||
| P/tB | 3.93 | ||
| EV/EBITDA | 10.73 |
EPS(TTM)6.79
EY6.99%
EPS(NY)7.74
Fwd EY7.97%
FCF(TTM)6.81
FCFY7.01%
OCF(TTM)7.1
OCFY7.31%
SpS25.83
BVpS25.97
TBVpS24.71
PEG (NY)1.02
PEG (5Y)N/A
Graham Number62.9837 (-35.14%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.49% | ||
| ROE | 24.9% | ||
| ROCE | 24.67% | ||
| ROIC | 19.49% | ||
| ROICexc | 56.96% | ||
| ROICexgc | 65.8% | ||
| OM | 26.12% | ||
| PM (TTM) | 25.03% | ||
| GM | 93.26% | ||
| FCFM | 26.35% |
ROA(3y)9.3%
ROA(5y)10.59%
ROE(3y)12.45%
ROE(5y)14.06%
ROIC(3y)10.37%
ROIC(5y)10.71%
ROICexc(3y)33.39%
ROICexc(5y)32.41%
ROICexgc(3y)39.93%
ROICexgc(5y)39.19%
ROCE(3y)13.12%
ROCE(5y)13.56%
ROICexgc growth 3Y17.25%
ROICexgc growth 5YN/A
ROICexc growth 3Y20.23%
ROICexc growth 5YN/A
OM growth 3Y13.93%
OM growth 5YN/A
PM growth 3Y35.6%
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y-0.55%
F-Score7
Asset Turnover0.74
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.03 | ||
| Debt/EBITDA | 0.02 | ||
| Cap/Depr | 63.1% | ||
| Cap/Sales | 1.15% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 98.43% | ||
| Profit Quality | 105.28% | ||
| Current Ratio | 3.32 | ||
| Quick Ratio | 3.25 | ||
| Altman-Z | 8.54 |
F-Score7
WACC9.11%
ROIC/WACC2.14
Cap/Depr(3y)66.35%
Cap/Depr(5y)125.36%
Cap/Sales(3y)1.35%
Cap/Sales(5y)2.48%
Profit Quality(3y)315.54%
Profit Quality(5y)253.68%
High Growth Momentum
Growth
EPS 1Y (TTM)414.39%
EPS 3Y34.67%
EPS 5YN/A
EPS Q2Q%25.87%
EPS Next Y13.99%
EPS Next 2Y16%
EPS Next 3Y11.72%
EPS Next 5Y-8.29%
Revenue 1Y (TTM)21.22%
Revenue growth 3Y14.84%
Revenue growth 5Y14.03%
Sales Q2Q%27.84%
Revenue Next Year11.92%
Revenue Next 2Y11.45%
Revenue Next 3Y8.53%
Revenue Next 5Y-0.83%
EBIT growth 1Y1102.71%
EBIT growth 3Y30.84%
EBIT growth 5YN/A
EBIT Next Year17.65%
EBIT Next 3Y17.42%
EBIT Next 5Y-9.47%
FCF growth 1Y443.87%
FCF growth 3Y14.94%
FCF growth 5YN/A
OCF growth 1Y321.52%
OCF growth 3Y13.38%
OCF growth 5YN/A
INCYTE CORP / INCY Fundamental Analysis FAQ
What is the fundamental rating for INCY stock?
ChartMill assigns a fundamental rating of 7 / 10 to INCY.
What is the valuation status of INCYTE CORP (INCY) stock?
ChartMill assigns a valuation rating of 7 / 10 to INCYTE CORP (INCY). This can be considered as Undervalued.
Can you provide the profitability details for INCYTE CORP?
INCYTE CORP (INCY) has a profitability rating of 9 / 10.
What is the valuation of INCYTE CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for INCYTE CORP (INCY) is 14.3 and the Price/Book (PB) ratio is 3.74.